Recent Advances in ADC Therapy for Active Brain Metastases in Breast Cancer
Brain metastases are a common and severe complication of metastatic breast cancer (MBC), with approximately 20% to 30% of patients experiencing brain metastases[1]. Among these, the incidence of brain metastases in HER2-positive MBC patients can reach 30% to 55%[2]; the incidence is also high in HER2-negative patients[3]. This makes MBC the second leading cause of … Read more
